An award-winning journalist and New York Times best-selling author, David Faber is a co-anchor of CNBC's "Squawk on the Street" (M-F: 9 a.m.-12 p.m. ET) and an anchor and co-producer of CNBC's acclaimed original documentaries and long-form programming.
During the day, Faber breaks news and provides in-depth analysis on a range of business topics during the "Faber Report." In his 20 years with CNBC, Faber has broken many big financial stories including the massive fraud at WorldCom, the bailout of the hedge fund Long Term Capital Management and Rupert Murdoch's unsolicited bid for Dow Jones.
Faber has reported nine documentaries for CNBC for which he has received Loeb, Emmy, Peabody and duPont awards.
His book, "The Faber Report," was published by Little, Brown in spring 2002; his second book, "And Then the Roof Caved In," was published in the summer of 2009 by John Wiley.
He holds a bachelor's degree in English from Tufts University.
Follow David Faber on Twitter
Genzyme and Sanofi-Aventis have reached a so called “agreement in principle” for a deal in which Sanofi will acquire Genzyme.
I thought Barry Sternlicht's, chairman and CEO of Starwood Capital Group, comment about the quickening race upward in commercial real estate values is one worth noting.
Rep. Barney Frank (D-Mass.), co-author of the Dodd-Frank law, said legislative efforts succeeded in discouraging the "perverse incentive" of the past by prompting companies to provide "more compensation in stock.
It’s shaping up to be a long fight. I’m talking about Community Health Systems’ hostile bid for Tenet Healthcare.
Dominion Resources, the Virginia-based power producer with a $25 billion market cap, upon learning of Duke Energy's plans to merge with Progress Energy, sent letters to both companies with soft offers to buy each at a 10- to 15-percent premium to their stock price as of last Friday, according to people familiar with the situation.
Bill Ackman, the activist investor whose Pershing Square Capital took a 16.5 percent ownership stake in J.C. Penney last fall, has not been pushing JCP to broadly pursue a transaction to create value, but rather has been engaged with the company in conversations about how it can improve its operations, according to sources.